Nelson Labs has expanded its capabilities by adding product-sterility testing at three laboratory sites in the U.S. and ...

Enzene’s two facilities in Pune, India have received European Union (EU) GMP certification to provide commercial-scale ...

Triggers a $20 million research payment to Evotec, enabling further development of a preclinical program in neurodegeneration ...

The FDA has approved TNKase, a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke (AIS) in ...

Will use Mural Link’s functionality related to clinical trial participant support services, communication tools, and ...

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s Stoboclo (CT-P41, denosumab-bmwo) and Osenvelt (CT-P41, ...

Micreos and Northway Biotech partner to develop scalable cGMP production processes for a biologic therapeutic aimed at ...

Bionova Scientific, a boutique commercial-scale biologics CDMO, has opened a new facility in Fremont, California.

Key regulatory trends laying the foundation for updated policies, risk-based regulatory frameworks, and forward-looking ...

Otulfi, an ustekinumab biosimilar for the reference product Stelara (ustekinumab), developed by Formycon AG, is now available ...

Repligen Corporation acquired 908 Devices’ desktop portfolio of 4 devices for bioprocessing process analytical technology (PAT) applications.

Callio Therapeutics, a biotechnology company, has launched with the closing of a $187.0 million Series A financing round.